MedPath

Study of tumor markers in terms of their importance in the grade and stage of stomach cancer.

Not Applicable
Completed
Conditions
Health Condition 1: C169- Malignant neoplasm of stomach, unspecified
Registration Number
CTRI/2021/05/033905
Lead Sponsor
Chittaranjan National Cancer Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
63
Inclusion Criteria

1. Patients who will be operated for gastric neoplasm and will be diagnosed with malignant

gastric epithelial neoplasms histopathologically.

2. Those who will give informed consent for taking part in the study.

Exclusion Criteria

1. After histopathological diagnosis all benign gastric neoplasms will be excluded.

2. After histopathological diagnosis gastric neoplasms other than malignant gastric epithelial

neoplasms will be excluded.

3. Cases where Neoadjuvant chemotherapy have been administered.

4. Those who are not willing to take part in the study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath